Insiders · Profile

Schimmelpennink Evert B.

President, CEO and Secretary at LENZ Therapeutics. Filing since 27 Mar 2026. CIK 0001713795

Company

Date

Role

Action

Amount

Of holding

27 Mar 2026

President, CEO and Secretary

Bought

28,089

$251.41K

57.1%

1 decision on file.